Full Press Release Details
| PROSPECTUS SUPPLEMENT | Filed Pursuant to Rule 424(b)(3) |
| (To Prospectus dated August 11, 2023) | Registration No. 333-271903 |
CANYON ACQUISITION CORP.
Murphy Canyon Road, Suite 300
MEETING OF STOCKHOLDERS
BE HELD ON SEPTEMBER 7, 2023
the Stockholders of Murphy Canyon Acquisition Corp.:
prospectus supplement amends and supplements the prospectus dated August 11, 2023 (the "Prospectus"), which forms a part
of the Registration Statement of Murphy Canyon Acquisition Corp. ("MURF") on Form S-4 (Registration No. 333-271903) (the
"Registration Statement"). The Prospectus and Registration Statement relate to an offering of securities of MURF to shareholders
of Conduit Pharmaceuticals Limited ("Conduit") in connection with the proposed merger (the "Merger") contemplated
by that certain Agreement and Plan of Merger, dated as of November 8, 2022 and as amended on January 27, 2023 and May 11, 2023 (the "Merger
Agreement"), which, among other things, provides for the merger of a wholly-owned subsidiary of MURF with and into Conduit, with
Conduit surviving the merger as a wholly-owned subsidiary of MURF. Capitalized terms used in this prospectus supplement and not otherwise
defined herein have the meanings specified in the Prospectus.
prospectus supplement is being filed to amend and supplement the information included in the Prospectus solely with the information set
| Provide an Amended and Restated Notice of Special Meeting of Stockholders; | ||
| Revise the order of the subproposals relating to approval of amendments to MURF's current amended and restated certificate of incorporation appearing in the Notice of Special Meeting of Stockholders and in the sections: "Summary on the Material Terms of the Transactions", "Questions and Answers About the Business Combination and Proposals", "Summary of the Proxy Statement/Prospectus", "Special Meeting of MURF Stockholders", "Charter Amendments Proposal", and "Advisory Charter Amendments Proposals" to conform with the order of subproposals on the proxy card; and | ||
| Provide a revised proxy card that includes, in conformity with the Prospectus, Charter Amendment Proposal F to require that stockholders only act at annual and special meetings of the corporation and not by written consent. |
following pages include such Amended and Restated Notice of the Special Meeting of Stockholders, amendments to the order of subproposals
in sections of the Prospectus, and a revised proxy card.
you previously submitted a proxy card or voting instruction form or submitted a proxy or voting instructions by mail or online, then
your previous voting instructions will continue to be honored with respect to the shares held by you and the respective proposals. With
respect to Charter Amendment Proposal F as set forth in the revised proxy card, MURF stockholders should vote on this proposal by internet,
phone or mail. A failure to vote by proxy or in person (at the virtual Special Meeting) on the matters covered by Charter Amendment Proposal
F as set forth in the revised proxy card will result in an abstention that will have the same effect as a vote "AGAINST"
Charter Amendment Proposal F.
you have not yet voted on any proposals, we urge you to vote. The Special Meeting will continue to be held on September 7, 2023 at 10:00
a.m., Eastern Time, via webcast. MURF stockholders can attend, vote and examine the list of MURF stockholders entitled to vote at the
live webcast of the Special Meeting by visiting www.proxyvote.com before the meeting or www.virtualshareholdermeeting.com/MURF2023SM2
during the meeting and entering the control number found on their proxy card, voting instruction form or notice they previously received.
prospectus supplement is not complete without the Prospectus. This prospectus supplement should be read in conjunction with the Prospectus, and is qualified by reference thereto, except to the extent that the information
in this prospectus supplement updates or supersedes the information contained in the Prospectus. Please keep this prospectus supplement
with your Prospectus for future reference.
you invest, you should read the Prospectus and the Registration Statement and other documents MURF has filed with the SEC for more complete
information about the issuer and this offering. You may obtain these documents for free by visiting EDGAR on the SEC website at www.sec.gov.
in our securities involves a high degree of risks. You should review carefully the risks and uncertainties described in the section titled
"Risk Factors" beginning on page 29 of the Prospectus, and under similar headings in any amendments or supplements to the
the SEC nor any state securities commission has approved or disapproved of the securities to be issued under the Prospectus or this prospectus
supplement or determined if the Prospectus or this prospectus supplement is truthful or complete.
date of this prospectus supplement is August 23, 2023.
you for your consideration and continued support.
Executive Officer, President and Chairman
AND RESTATED NOTICE OF
MEETING OF STOCKHOLDERS
BE HELD ON SEPTEMBER 7, 2023
THE STOCKHOLDERS OF MURPHY CANYON ACQUISITION CORP.:
IS HEREBY GIVEN that a special meeting of stockholders of Murphy Canyon Acquisition Corp. ("MURF"), a Delaware corporation,
will be held at 10:00 a.m., Eastern Time, on September 7, 2023, via webcast (the "Special Meeting"). MURF stockholders can
attend, vote and examine the list of MURF stockholders entitled to vote at the live webcast of the Special Meeting by visiting www.proxyvote.com
before the meeting or www.virtualshareholdermeeting.com/MURF2023SM2 during the meeting and entering the control number found on
their proxy card, voting instruction form or notice they previously received. In light of public health concerns regarding the novel
coronavirus (COVID-19), the Special Meeting will be held in a virtual meeting format only. You will not be able to attend the Special
are cordially invited to virtually attend the Special Meeting, which will be held for the following purposes:
| (1) | to consider and vote upon a proposal to approve the business combination (the "Business Combination") described in this proxy statement/prospectus, including the Agreement and Plan of Merger, dated as of November 8, 2022 and as amended on January 27, 2023 and May 11, 2023 (the "Merger Agreement"), by and among MURF, Conduit Pharmaceuticals Limited, a Cayman Islands exempted company ("Conduit") and Conduit Merger Sub, Inc., a Cayman Islands exempted company and a wholly-owned subsidiary of MURF ("Merger Sub"), which, among other things, provides for the merger of Merger Sub with and into Conduit, with Conduit surviving the merger as a wholly-owned subsidiary of MURF - we refer to this proposal as the "business combination proposal"; | |
| (2) | to consider and vote upon separate proposals to approve amendments to MURF's current amended and restated certificate of incorporation to: |
| (i) | Charter Amendment Proposal A - change the name of the public entity from "Murphy Canyon Acquisition Corp." to "Conduit Pharmaceuticals Inc." ("New Conduit"); | |
| (ii) | Charter Amendment Proposal B - provide for one class of authorized common stock; | |
| (iii) | Charter Amendment Proposal C - delete the various provisions in MURF's current amended and restated certificate of incorporation applicable only to special purpose acquisition corporations (such as the obligation to dissolve and liquidate if a business combination is not consummated within a certain period of time); | |
| (iv) | Charter Amendment Proposal D - increase the number of authorized shares of common stock to 250,000,000; and | |
| (v) | Charter Amendment Proposal E - fix the number of directors at seven (7), a majority of whom shall be independent directors in accordance with The Nasdaq Stock Market LLC's requirements - we refer to these proposals collectively as the "charter amendment proposals"; | |
| (vi) | Charter Amendment Proposal F - require that stockholders only act at annual and special meetings of the corporation and not by written consent- we refer to these proposals collectively as the "charter amendment proposals"; |
| (3) | to consider and vote upon, on a non-binding advisory basis, certain governance provisions in the Proposed Charter, presented separately in accordance with U.S. Securities and Exchange Commission ("SEC") requirements - we refer to this proposal as the "advisory charter amendments proposals"; | |
| (4) | to elect seven (7) directors who, upon consummation of the Business Combination, will be the directors of New Conduit - we refer to this proposal as the "director election proposal"; |
| (5) | to consider and vote upon a proposal to approve the Conduit Pharmaceuticals Inc. 2023 Stock Incentive Plan (named in anticipation of the Business Combination), which is an incentive compensation plan for employees of New Conduit and its subsidiaries, including Conduit - we refer to this proposal as the "incentive plan proposal"; | |
| (6) | to consider and vote upon a proposal to approve, for purposes of complying with applicable listing rules of Nasdaq, the issuance of New Conduit common stock and warrants to purchase New Conduit common stock, par value $0.0001 per share, to Prospect Science Ventures Limited (the "Private Placement Investor") in the Private Placement, the proceeds of which will be used to finance the Business Combination and related transactions and the costs and expenses incurred in connection therewith with any balance used for working capital purposes - we refer to this proposal as the "Nasdaq proposal"; and | |
| (7) | to consider and vote upon a proposal to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if MURF does not have sufficient proxies to approve one or more of the foregoing proposals - we refer to this proposal as the "adjournment proposal." |
items of business are described in the proxy statement/prospectus first mailed on or around August 11, 2023, to stockholders of record
of MURF as of the Record Date, as amended by the attached prospectus supplement. We encourage you to read both in their entirety before
voting. Only holders of record of MURF common stock at the close of business on August 2, 2023 (the "Record Date"), are entitled
to notice of the Special Meeting and to vote and have their votes counted at the Special Meeting and any adjournments or postponements
of the Special Meeting.
careful consideration, the MURF Board has determined that the business combination proposal, the charter amendment proposals, the advisory
charter amendments proposals, the director election proposal, the incentive plan proposal, the Nasdaq proposal and the adjournment proposal
are fair to and in the best interests of MURF and its stockholders and unanimously recommends that you vote or give instruction to vote
"FOR" the business combination proposal, "FOR" each of the charter amendment proposals, "FOR" each
of the advisory charter amendments proposals, "FOR" the election of all of the persons nominated by MURF's management
for election as directors, "FOR" the incentive plan proposal, "FOR" the Nasdaq proposal and "FOR"
the adjournment proposal, if presented.
of the Transactions (as described in the proxy statement/prospectus first mailed on or around August 11, 2023, to stockholders of record
of MURF as of the Record Date) is conditioned on approval of each of the business combination proposal, the charter amendment proposals,
the director election proposal, the incentive plan proposal, and the Nasdaq proposal. If any of the proposals is not approved, the other
proposals will not be presented to stockholders for a vote.
MURF stockholders are cordially invited to virtually attend the Special Meeting, which will be held via live webcast. To ensure your
representation at the Special Meeting, however, you are urged to complete, sign, date and return the enclosed proxy card as soon as possible.
If you are a stockholder of record of MURF common stock, you may also cast your vote at the Special Meeting electronically by visiting
www.proxyvote.com before the meeting or www.virtualshareholdermeeting.com/MURF2023SM2 during the meeting. If your shares are held in
an account at a brokerage firm or bank, you must instruct your broker or bank on how to vote your shares or, if you wish to attend the
Special Meeting virtually and vote electronically, obtain a proxy from your broker or bank.
complete list of MURF stockholders of record entitled to vote at the Special Meeting will be available for ten days before the Special
Meeting at the principal executive offices of MURF for inspection by stockholders during ordinary business hours for any purpose germane
to the Special Meeting.
vote is important regardless of the number of shares you own. Whether you plan to virtually attend the Special Meeting or not, please
sign, date and return the enclosed proxy card as soon as possible in the envelope provided. If your shares are held in "street
name" or are in a margin or similar account, you should contact your broker to ensure that votes related to the shares you beneficially
own are properly counted.
you for your participation. We look forward to your continued support.
| By Order of the Board of Directors | |
| /s/ Jack K. Heilbron | |
| Jack K. Heilbron | |
| Chief Executive Officer, President, and Chairman | |
| August 23, 2023 |
YOU ARE A HOLDER OF PUBLIC SHARES AND WISH TO EXERCISE YOUR REDEMPTION RIGHTS, YOU MUST DEMAND THAT MURF REDEEM YOUR SHARES FOR CASH
BY DELIVERING YOUR STOCK ELECTRONICALLY TO MURF'S TRANSFER AGENT USING DEPOSITORY TRUST COMPANY'S DWAC (DEPOSIT WITHDRAWAL
AT CUSTODIAN) SYSTEM. MURF'S TRANSFER AGENT MUST RECEIVE YOUR INSTRUCTION TO REDEEM BY 5:00 PM EASTERN TIME ON SEPTEMBER 5, 2023
(TWO (2) BUSINESS DAYS BEFORE THE SPECIAL MEETING) IN ORDER FOR YOUR REDEMPTION DEMAND TO BE VALID. IN ORDER TO EXERCISE YOUR REDEMPTION
RIGHT, YOU NEED TO IDENTIFY YOURSELF AS A BENEFICIAL HOLDER AND PROVIDE YOUR LEGAL NAME, PHONE NUMBER AND ADDRESS IN YOUR WRITTEN DEMAND.
SEE "SPECIAL MEETING OF MURF STOCKHOLDERS - REDEMPTION RIGHTS" FOR MORE SPECIFIC INSTRUCTIONS.
THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES REGULATORY AGENCY HAS APPROVED OR DISAPPROVED THE TRANSACTIONS DESCRIBED
IN THIS JOINT PROXY STATEMENT/PROSPECTUS, PASSED UPON THE MERITS OR FAIRNESS OF THE MERGER OR RELATED TRANSACTIONS OR PASSED UPON THE
ADEQUACY OR ACCURACY OF THE DISCLOSURE IN THIS PROXY STATEMENT/PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY CONSTITUTES A CRIMINAL
proxy statement/prospectus dated August 11, 2023, was first mailed to Murphy Canyon Acquisition Corp. stockholders on or about August
Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held on September 7, 2023. MURF's proxy
statement/prospectus are available at www.proxyvote.com.
following amendments should be read in conjunction with the Prospectus, which should be read in its entirety. Without admitting in any
way that the disclosures below are material or otherwise required by law, MURF makes the following supplemental disclosures.